Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorazepam for salivary cortisol response in children undergoing digestive endoscopy
NCT03180632Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire Sainte-Justine
- Start
- Jun 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lorazepam in anxiety disorder, sponsored by Centre Hospitalier Universitaire Sainte-Justine. Started Jun 2017; status: completed.
02
Drugs
lorazepam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT03180632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180632.